ACW 4.17% 2.3¢ actinogen medical limited

Ann: Positive Xanamem brain PET study peer-reviewed publication, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,588 Posts.
    lightbulb Created with Sketch. 68

    the price action might be how true is the phrase "Xanamem is the first drug of this classto have such compelling data" in the current announcment.

    Below is the excerpt...

    "To our knowledge Xanamem is the first drug of this classto have such compelling data. The PET study
    highlights just how effective Xanamem is at reaching its target enzyme in the brain. No other inhibitor of 11βHSD1 has ever demonstrated robust central nervous system (CNS) target engagement in this way."

    Can someone validate "Xanamem is the first drug of this class to have such compelling data" if correct?

    dyor

    Last edited by lloydray: 25/01/24
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
2.3¢
Change
-0.001(4.17%)
Mkt cap ! $70.90M
Open High Low Value Volume
2.5¢ 2.5¢ 2.3¢ $103.7K 4.298M

Buyers (Bids)

No. Vol. Price($)
11 3587976 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 50000 1
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.